Beaumont Financial Advisors, LLC Moderna, Inc. Transaction History

Beaumont Financial Advisors, LLC

  • $1.11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023
BUY
$118.5 - $160.53 $1.06 Million - $1.43 Million
8,921 Added 587.68%
10,439 $1.27 Million
Q1 2023

May 08, 2023
SELL
$135.66 - $197.02 $8,682 - $12,609
-64 Reduced 4.05%
1,518 $233,000
Q4 2022

Jan 25, 2023
BUY
$118.38 - $210.04 $187,277 - $332,283
1,582 New
1,582 $0

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Beaumont Financial Advisors, LLC Portfolio

Follow Beaumont Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email